Product Description

A key strategy that will allow BannerBio to obtain considerable advantage in the development and commercialization of its unique bioactive ingredients is its long-standing and continued effort to establish cooperative research agreements with select well-known Universities and Institutes from the USA. An immediate result of such collaboration was the creation of BannerBio's unique microencapsulation technology referred to as "NanoEncaps®" which will provide both national and international terminal manufacturers with a bioactive ingredient formulation which overcomes the traditional problems instability, insolubility, reduced fluidity and bioavailability, all associated with decreased efficacy.